Post-marketing safety surveillance of vortioxetine hydrobromide
A pharmacovigilance study leveraging Faers database
Bibliographic Data
| ID | 15517673 |
|---|---|
| Authors | Ying Zhang (0000-0001-6214-2440, Shandong University of Traditional Chinese Medicine), Shengzhu Sun (Shandong University of Traditional Chinese Medicine), Yaogui Ning (0000-0002-6394-9032, Shandong University of Traditional Chinese Medicine, corresponding author), Yunhong Ning |
| Year | 2025 |
| Volume | 16 |
| Pages | 1532803-1532803 |
| Publication date | 2025-02-24 |
| Open Access | Yes |
| Type | ARTICLE |
| Venue | Frontiers in Psychiatry (JOURNAL) |
| Journal identifiers | ISSN: 1664-0640 • E-ISSN: 1664-0640 |
| Publisher | Frontiers Media (PUBLISHER • CH) |
| DOI | 10.3389/fpsyt.2025.1532803 |
| PMID | 40066137 |
| OpenAlex | W4407895492 |
| Language | EN |
| Citations received | 1 |
| References cited | 35 |
This study identified adverse events (AEs) associated with vortioxetine. Our findings offer valuable insights for optimizing the use of vortioxetine hydrobromide and reducing potential side effects, serving as a reference for its rational and safe clinical application
Adverse effect · Business · Drug · Major depressive disorder · Mood · Pharmacovigilance · Postmarketing surveillance · Psychiatry · Vortioxetine · Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes · Electroconvulsive Therapy Studies · Medicine · Treatment of Major Depression · Pharmacology
| Citations per year | 1 |
|---|---|
| Citation span | 2025 - 2025 (1) |
| Highly cited | No |